Original breve
Niveles de fármacos anti-TNFα en pacientes con artritis reumatoide y espondiloartritis
Anti-TNFα Drug Levels in Patients with Rheumatoid Arthritis and Spondyloarthritis
Erardo Meriño-Ibarra
, Francisco Javier Manero Ruíz
Autor para correspondencia
Servicio de Reumatología, Hospital Universitario Miguel Servet, Zaragoza, España
Leído
3907
Vecesse ha leído el artículo
977
Total PDF
2930
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 9 | 30 | 39 |
| 2025 5 | 119 | 62 | 181 |
| 2025 4 | 130 | 35 | 165 |
| 2025 3 | 130 | 34 | 164 |
| 2025 2 | 140 | 35 | 175 |
| 2025 1 | 166 | 57 | 223 |
| 2024 12 | 118 | 35 | 153 |
| 2024 11 | 166 | 65 | 231 |
| 2024 10 | 116 | 51 | 167 |
| 2024 9 | 162 | 23 | 185 |
| 2024 8 | 148 | 40 | 188 |
| 2024 7 | 149 | 39 | 188 |
| 2024 6 | 125 | 38 | 163 |
| 2024 5 | 112 | 41 | 153 |
| 2024 4 | 132 | 23 | 155 |
| 2024 3 | 78 | 31 | 109 |
| 2024 2 | 79 | 21 | 100 |
| 2024 1 | 60 | 29 | 89 |
| 2023 12 | 70 | 20 | 90 |
| 2023 11 | 76 | 43 | 119 |
| 2023 10 | 76 | 34 | 110 |
| 2023 9 | 127 | 43 | 170 |
| 2023 8 | 102 | 17 | 119 |
| 2023 7 | 73 | 25 | 98 |
| 2023 6 | 93 | 26 | 119 |
| 2023 5 | 81 | 34 | 115 |
| 2023 4 | 57 | 21 | 78 |
| 2023 3 | 8 | 7 | 15 |
| 2022 1 | 1 | 0 | 1 |
| 2022 11 | 2 | 4 | 6 |
| 2022 10 | 15 | 6 | 21 |
| 2022 8 | 1 | 0 | 1 |
| 2022 7 | 1 | 0 | 1 |
| 2022 6 | 1 | 0 | 1 |
| 2022 5 | 1 | 0 | 1 |
| 2022 3 | 1 | 2 | 3 |
| 2022 2 | 1 | 2 | 3 |
| 2021 1 | 1 | 2 | 3 |
| 2021 12 | 1 | 0 | 1 |
| 2021 10 | 2 | 2 | 4 |
Mostrar todo
